Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

Acknowledgment of Support

This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Mentors in Medicine Series on Applied Precision Medicine: Focus on Choosing the Best Frontline Treatment in Multiple Myeloma

Release Date: February 18, 2021
Expiration Date: February 18, 2022

Activity Overview

This online, on-demand, case-based, CME-certified webcast brings together renowned experts in the treatment of multiple myeloma. It provides guidance for practicing oncologists on how to incorporate biomarker testing into everyday clinical practice, to determine diagnosis, risk stratification, and prognostic information, as well as inform frontline treatment selection for their patients with multiple myeloma. The panel analyzes recent clinical trial evidence to optimize therapeutic strategies, using real patient cases as a starting point. Each case includes an expert analysis of Show Me the Data®, as well as Key Takeaways 4 Tomorrow that can be applied immediately in oncology clinical practice.

This educational activity is an archive of the live virtual webcast held on February 11, 2021.

Acknowledgement of Commercial Support

This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is intended for oncologists and hematologists involved in the treatment of patients with multiple myeloma. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of multiple myeloma are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Incorporate biomarker testing into the diagnosis and/or therapy selection for the treatment of patients with multiple myeloma
  • Analyze recent data on the efficacy and safety of therapeutic options for the treatment of patients with multiple myeloma
  • Apply optimal management strategies in the treatment of patients with multiple myeloma based on recent clinical trial findings

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Series Chair

Andre H. Goy, MD
Andre H. Goy, MD
Physician in Chief
Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer – John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology – Hackensack Meridian School of Medicine
Professor of Medicine – Georgetown University
Hackensack, NJ

Disclosures: Grant/Research Support: PI- Acerta, AstraZeneca, Celgene, Constellation, Genentech-Hoffmann La Roche, Infinity, Infinity Verastem, Janssen, Karyopharm, Kite Pharma, Pharmacyclics; Consultant: Acerta, Celgene, Gilead, Janssen, Kite Pharma, Xcenda; Stock/Shareholder: COTA; Other: Honoraria: Kite, Gilead, Celgene, AstraZeneca, Xcenda; Advisory: AstraZeneca, COTA, Elsevier’s PracticeUpdate Oncology, Gilead, Janssen, Kite Pharma.


Noa Biran, MD
Noa Biran, MD
Assistant Professor
Department of Medicine
Hackensack Meridian School of Medicine
Multiple Myeloma Division
John Theurer Cancer Center
Hackensack, NJ

Disclosures: Grant/Research Support: Merck; BMS; Karyopharm; Janssen; Consultant: Sanofi; Speaker’s Bureau: Janssen; Sanofi.


Melissa Alsina, MD
Melissa Alsina, MD
Professor of Medicine
Head, Myeloma Bone Marrow Transplant and Cellular Immunotherapy Program
Senior Member, Malignant Hematology Program
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL

Disclosures: Grant/Research Support: BMS; Consultant: BMS, Janssen; Speakers Bureau: Janssen, GSK.

Kenneth C. Anderson, MD
Kenneth C. Anderson, MD
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Kraft Family Professor of Medicine
Harvard Medical School
Physician, Oncology
Brigham and Women's Hospital
Boston, MA

Disclosures: Consultant: Pfizer; Amgen; Janssen; AstraZeneca; Gilead, Precision BioSciences; Stock/Shareholder: C4 Therapeutics.

Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Professor and Chair
Department of Hematology and Medical Oncology
Anne and Bernard Gray Professor in Cancer
Emory University School of Medicine
Chief Medical Officer
Winship Cancer Institute
Emory University
Atlanta, GA

Disclosures: Grant/Research Support: Celgene (Clinical trials), Janssen, Takeda; Consultant: AbbVie, Amgen, BMS, Celgene; GSK; Janssen; Sanofi; Takeda; Stock/Shareholder: C4 Therapeutics (Board of Directors with stock)

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By